| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |